Odysseas Kostas D 4
4 · Armata Pharmaceuticals, Inc. · Filed Apr 15, 2022
Insider Transaction Report
Form 4
Kostas Odysseas D
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-04-13+33,000→ 33,000 totalExercise: $5.11Exp: 2032-04-13→ Common Stock (33,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant.